Skip to content
CNS Clinical Research

Bethesda, Maryland

CNS clinical trials in Bethesda, MD

54 CNS studies are recruiting participants at sites in Bethesda as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Bethesda at a glance

  • 54 studies are recruiting at a site in Bethesda.
  • By phase: Phase 1 (8), Phase 1/2 (2), Phase 2 (6), Phase 3 (5), No phase (3), Observational (30). Studies of devices and behavioral approaches have no phase.
  • By sponsor: government (43), industry (8), university, hospital or other (3).
  • By research area: Depression (14), Epilepsy (14), Multiple Sclerosis (14), ADHD (5), Parkinson's Disease (5), Bipolar Disorder (1), Migraine (1).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in Bethesda

Basic details from each study's public record (the 30 most recently updated of 54). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

    • Phase 2
    • Ages 8 to 65
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00018057 · updated
  2. Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

    • Phase 1
    • Ages 18 to 70
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT03973268 · updated
  3. Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

    • Phase 1
    • Ages 18 to 65
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT03065335 · updated
  4. Natural History of Depression, Bipolar Disorder and Suicide Risk

    • Observational
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT06462196 · updated
  5. Characterization and Treatment of Adolescent Depression

    • Observational
    • Ages 11 to 25
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT03388606 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Bethesda, MD on ClinicalTrials.gov.

ADHD studies recruiting in Bethesda

  1. Developing Brain, Impulsivity and Compulsivity

    • Observational
    • Ages 6 to 80
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT04631042 · updated
  2. Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy

    • Observational
    • Ages 8 to 17
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT07640802 · updated
  3. Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool

    • Observational
    • Ages 8 to 13
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT07764536 · updated
  4. Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

    • Phase 1/2
    • Ages 8 to 16
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT05608434 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Bethesda, MD on ClinicalTrials.gov.

Parkinson's disease studies recruiting in Bethesda

  1. Deep Brain Stimulation Surgery for Movement Disorders

    • No phase
    • Ages 18 to 99
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT01581580 · updated
  2. Deep Brain Stimulation Therapy in Movement Disorders

    • No phase
    • Ages 18 to 100
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT02119611 · updated
  3. Evaluation and Treatment of Neurosurgical Disorders

    • Observational
    • Ages 4 to 99
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00060541 · updated
  4. PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    National Institute of Mental Health (NIMH)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT04396873 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Bethesda, MD on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Bethesda

  1. Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

    • Observational
    • From 1 month, up to 99 years
    • All sexes
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00794352 · updated
  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    National Cancer Institute Developmental Therapeutics Clinic
    Registry record
    NCT03816345 · updated
  3. Role of Genetic Factors in the Development of Lung Disease

    • Observational
    • Ages 2 to 90
    • All sexes
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00001532 · updated
  4. Study of the Disease Process of Lymphangioleiomyomatosis

    • Observational
    • Ages 16 to 100
    • All sexes
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00001465 · updated
  5. Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

    • Observational
    • Ages 2 to 120
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT01730131 · updated
  6. Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

    • Observational
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00001248 · updated
  7. Study of Skin Tumors in Tuberous Sclerosis

    • Observational
    • Ages 18 to 90
    • All sexes
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT00001975 · updated
  8. Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

    • Phase 1/2
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT03109288 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Bethesda, MD on ClinicalTrials.gov.

Epilepsy studies recruiting in Bethesda

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Registry record
    NCT07563881 · updated
  2. Tumor Related Epilepsy

    • Observational
    • Ages 8 to 99
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT02639325 · updated
  3. Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

    • Phase 3
    • Ages 4 to 55
    • All sexes
    Sponsor
    SK Life Science, Inc.
    Study site
    Mid-Atlantic Epilepsy and Sleep Center
    Registry record
    NCT05219617 · updated
  4. A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

    • Phase 3
    • Ages 12 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    Mid-Atlantic Epilepsy and Sleep Center
    Registry record
    NCT05667142 · updated
  5. A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Xenon Pharmaceuticals Inc.
    Study site
    Mid-Atlantic Epilepsy and Sleep Center
    Registry record
    NCT05716100 · updated
  6. Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

    • Phase 1
    • Ages 18 to 60
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT02531880 · updated
  7. Surgery as a Treatment for Medically Intractable Epilepsy

    • Observational
    • Ages 8 to 99
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT01273129 · updated
  8. Investigating Epilepsy: Screening and Evaluation

    • Observational
    • Ages 8 to 110
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT03478852 · updated
  9. Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

    • Observational
    • Ages 8 to 120
    • All sexes
    Sponsor
    National Institute of Neurological Disorders and Stroke (NINDS)
    Study site
    National Institutes of Health Clinical Center
    Registry record
    NCT02107989 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Bethesda, MD on ClinicalTrials.gov.

Ask about studies near Bethesda

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Maryland

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call